Patent application number | Description | Published |
20090060999 | PROTEIN FORMULATION - The present invention relates to a new and improved low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, intended to be used as therapeutic, as prophylactic and/or as cosmetic agent. In the present invention, said active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or cell-occlusive. The active enamel substance can be incorporated into the polymeric matrix so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. | 03-05-2009 |
20090136575 | Protein Formulation - The present invention relates to a new and improved low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, intended to be used as therapeutic, as propylacetic and/or as cosmetic agent. In the present invention, said active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or cell-occlusive. The active enamel substance can be incorporated into the polymeric matrix so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. Comprised in the invention is thus in particular a new pharmaceutical and/or cosmetic formulation of an active enamel substance at a lower total concentration within the formulation, wherein a spatial and/or selective regulation of release of said active enamel substance permits a greater percentage of the active enamel substance to be released at the time of appropriate cellular activity. | 05-28-2009 |
20110312891 | ENAMEL MATRIX DERIVATIVE FRACTION C - Isolated active compound of a naturally occurring fraction of Enamel Matrix Derivatives (EMD), having at least one of each two N-terminal polypeptide fragments of amelogenin, which are at least 95% identical to an amino acid sequence as shown in SEQ. ID. No:1 and/or 2. The invention relates to the use of said isolated active compound of a fraction and/or of the fraction itself, and/or the at least one of each two polypeptide fragments for use as a medicament and/or for the manufacture of a pharmaceutical composition for a variety of different medical indications such as inducing and/or promoting cementogenesis, bone growth and/or binding between parts of living mineralised tissue, for bonding of a piece of living mineralised tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, for inducing regeneration of dentin, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma. | 12-22-2011 |
20120129129 | MEDICAL CLEANING KIT - The present invention relates to the field of cleaning and/or conditioning of biological and dental implant surfaces. More particularly, the invention relates to a kit comprising a) a cleaning device said cleaning device ( | 05-24-2012 |
20120308623 | COMPOSITION COMPRISING NANOPARTICLES OF TI02 - The present invention is directed to a composition comprising nanoparticles of TiO | 12-06-2012 |
20140295378 | Bio-Resorbable Debride or Implant Cleaning Tool and Method of Manufacturing the Same - The present invention is directed to a debridement and/or implant cleaning tool ( | 10-02-2014 |
20150132391 | COMPOSITION COMPRISING NANOPARTICLES OF TI02 - The present invention is directed to a composition comprising nanoparticles of TiO | 05-14-2015 |
20150209474 | METHOD FOR PRODUCING AN ALGINATE COATED TITANIUM DIOXIDE SCAFFOLD - The present document is directed to medical prosthetic devices used for implantation to replace and/or restore lost functions in a body. The document discloses a method for producing an alginate coated titanium dioxide scaffold wherein the alginate coating optionally comprises a biologically active substance. | 07-30-2015 |